Literature DB >> 18534717

Blockade of GABA synthesis only affects neural excitability under activated conditions in rat hippocampal slices.

Nese Dericioglu1, Cheryl L Garganta, Ognen A Petroff, Dara Mendelsohn, Anne Williamson.   

Abstract

The primary goal of this study was to establish whether inhibition of GABA synthesis was sufficient to induce network hyperexcitability in a rat hippocampal slice model comparable to that seen with GABA receptor blockade. We used field and intracellular recordings from the CA1 region of rat hippocampal slices to determine the physiological effects of blocking GABA synthesis with the convulsant, 3-mercaptoproprionic acid (MPA). We measured the rate of synthesis of GABA and glutamate in slices using 2-13C-glucose as a label source and liquid chromatography-tandem mass spectrometry. There was little effect of 3.5mM MPA on evoked events under control recording conditions. Tissue excitability was enhanced following a series of stimulus trains; this effect was enhanced when GABA transport was blocked. Evoked inhibitory potentials (IPSPs) failed following repetitive stimulation and MPA. Spontaneous epileptiform activity was seen reliably with elevated extracellular potassium (5mM). GABA synthesis decreased by 49% with MPA alone and 45% with the combination of MPA and excess potassium; GABA content was not substantially altered. Our data indicate: (1) GABAergic inhibition cannot be significantly compromised by MPA without network activation; (2) GABAergic synaptic inhibition is mediated by newly synthesized GABA; (3) there is a depletable pool of GABA that can sustain GABAergic inhibition when synthesis is impaired under basal, but not activated conditions; (4) overt hyperexcitability is only seen when newly synthesized GABA levels are low.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18534717      PMCID: PMC2535818          DOI: 10.1016/j.neuint.2008.04.006

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  58 in total

1.  Dynamic regulation of synaptic GABA release by the glutamate-glutamine cycle in hippocampal area CA1.

Authors:  Shu-Ling Liang; Gregory C Carlson; Douglas A Coulter
Journal:  J Neurosci       Date:  2006-08-16       Impact factor: 6.167

2.  Different metabolism of glutamatergic and GABAergic compartments in superfused hippocampal slices characterized by nuclear magnetic resonance spectroscopy.

Authors:  J M N Duarte; R A Cunha; R A Carvalho
Journal:  Neuroscience       Date:  2006-12-29       Impact factor: 3.590

3.  Physiological activity depresses synaptic function through an effect on vesicle priming.

Authors:  Krista L Moulder; Xiaoping Jiang; Amanda A Taylor; John W Olney; Steven Mennerick
Journal:  J Neurosci       Date:  2006-06-14       Impact factor: 6.167

4.  An investigation into the pharmacokinetics of 3-mercaptopropionic acid and development of a steady-state chemical seizure model using in vivo microdialysis and electrophysiological monitoring.

Authors:  Eric W Crick; Ivan Osorio; Naresh C Bhavaraju; Thomas H Linz; Craig E Lunte
Journal:  Epilepsy Res       Date:  2007-03-26       Impact factor: 3.045

5.  Horizontal spread of synchronized activity in neocortex and its control by GABA-mediated inhibition.

Authors:  Y Chagnac-Amitai; B W Connors
Journal:  J Neurophysiol       Date:  1989-04       Impact factor: 2.714

6.  Modulation of epileptiform activity by glutamine and system A transport in a model of post-traumatic epilepsy.

Authors:  Hiroaki Tani; Anita E Bandrowski; Isabel Parada; Michelle Wynn; John R Huguenard; David A Prince; Richard J Reimer
Journal:  Neurobiol Dis       Date:  2006-10-27       Impact factor: 5.996

7.  Time-related loss of glutamine from hippocampal slices and concomitant changes in neurotransmitter amino acids.

Authors:  I M Kapetanovic; W D Yonekawa; H J Kupferberg
Journal:  J Neurochem       Date:  1993-09       Impact factor: 5.372

8.  Kinetic differences between the isoforms of glutamate decarboxylase: implications for the regulation of GABA synthesis.

Authors:  Gino Battaglioli; Hongcheng Liu; David L Martin
Journal:  J Neurochem       Date:  2003-08       Impact factor: 5.372

9.  Long-term increase of glutamate decarboxylase mRNA in a rat model of temporal lobe epilepsy.

Authors:  S Feldblum; R F Ackermann; A J Tobin
Journal:  Neuron       Date:  1990-09       Impact factor: 17.173

10.  Motor and electrocorticographic epileptic activity induced by 3-mercaptopropionic acid in immature rats.

Authors:  P Mares; H Kubová; A Zouhar; J Folbergrová; H Koryntová; L Stanková
Journal:  Epilepsy Res       Date:  1993-09       Impact factor: 3.045

View more
  7 in total

Review 1.  The importance of the excitatory amino acid transporter 3 (EAAT3).

Authors:  Walden E Bjørn-Yoshimoto; Suzanne M Underhill
Journal:  Neurochem Int       Date:  2016-05-24       Impact factor: 3.921

Review 2.  A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra.

Authors:  Caroline D Rae
Journal:  Neurochem Res       Date:  2013-11-21       Impact factor: 3.996

3.  Metabolite concentration changes associated with positive and negative BOLD responses in the human visual cortex: A functional MRS study at 7 Tesla.

Authors:  Yohan Boillat; Lijing Xin; Wietske van der Zwaag; Rolf Gruetter
Journal:  J Cereb Blood Flow Metab       Date:  2019-02-12       Impact factor: 6.200

4.  Microperfusion of 3-MPA into the brain augments GABA.

Authors:  Andrew P Mayer; Ivan Osorio; Craig E Lunte
Journal:  Epilepsy Behav       Date:  2013-10-02       Impact factor: 2.937

5.  Rapid, activity-independent turnover of vesicular transmitter content at a mixed glycine/GABA synapse.

Authors:  Pierre F Apostolides; Laurence O Trussell
Journal:  J Neurosci       Date:  2013-03-13       Impact factor: 6.167

6.  Maintenance of thalamic epileptiform activity depends on the astrocytic glutamate-glutamine cycle.

Authors:  Astra S Bryant; Bojia Li; Mark P Beenhakker; John R Huguenard
Journal:  J Neurophysiol       Date:  2009-09-09       Impact factor: 2.714

7.  Medium-chain fatty acids improve cognitive function in intensively treated type 1 diabetic patients and support in vitro synaptic transmission during acute hypoglycemia.

Authors:  Kathleen A Page; Anne Williamson; Namyi Yu; Ewan C McNay; James Dzuira; Rory J McCrimmon; Robert S Sherwin
Journal:  Diabetes       Date:  2009-02-17       Impact factor: 9.461

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.